The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
Open accessAbstract
A previous study (LMB89) of the French Society of Pediatric Oncology for childhood mature B-cell lymphoma (B-NHL) demonstrated a 92% 3-year event-free survival (EFS) for intermediate-risk group B defined as “non-resected” stage I/II and CNS-negative advanced-stage III/IV (70% of cases). We performed the FAB/LMB96 trial to assess the possibility of reducing treatment in children/adolescents with intermediate-risk B-NHL without jeopardizing survival. “Early responding” patients (tumor response > 20% at day 7) were randomized in a factorial design between 4 arms, 2 receiving half-dose of cyclophosphamide in the second induction course with cyclophosphamide, Oncovin (vincristine), prednisone, Adriamycin (doxorubicin), methotrexate (COPADM) and 2 not receiving the maintenance course M1. A total of 657 patients were randomized (May 1996 to June 2001) and 637 were analyzed. The analysis showed no significant effect of any of the treatment reductions on EFS and survival. The 4-year EFS was 93.4% and 90.9% in the groups with full-dose and half-dose of cyclophosphamide (RR = 1.3, P = .40) and 91.9% and 92.5% in the groups with and without M1 (RR = 1.01, P = .98). There was no interaction between the 2 treatment reductions or between each treatment reduction and LDH level or histologic subtypes (Burkitt/Burkitt-like or large B-cell). Children/adolescents with intermediate-risk B-NHL who have an early response and achieve a complete remission after the first consolidation course can be cured with a 4-course treatment with a total dose of only 3.3 g/m2 cyclophosphamide and 120 mg/m2 doxorubicin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patte, C. (2001) · Blood · doi:10.1182/blood.v97.11.3370 · Cited by 538
Self-citationSpaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Rubinstein, L. V., Gail, M. H., & Santner, T. J. (1981) · Journal of Chronic Diseases · doi:10.1016/0021-9681(81)90007-2 · Cited by 267
Cairo, M. S., Sposto, R., Perkins, S. L., Meadows, A. T., Hoover‐Regan, M. L., Anderson, J. R., Siegel, S. E., Lones, M. A., Tedeschi‐Blok, N., Kadin, M. E., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04134.x · Cited by 179
Self-citationGroup sequential procedures: Calendar versus information time
Lan, K. K. G., & Demets, D. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780081003 · Cited by 168
Bowman, W. P., Shuster, J. J., Cook, B., Griffin, T., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1252 · Cited by 166
Psychological functioning of adolescent and young adult survivors of pediatric malignancy
Elkin, T. D., Phipps, S., Mulhern, R. K., & Fairclough, D. L. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199712)29:6<526::aid-mpo2>3.0.co;2-m · Cited by 138
Atra, A., Gerrard, M., Hobson, R., Imeson, J., Ashley, S., & Pinkerton, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.379 · Cited by 66
Self-citationAtra, A., Imeson, J., Hobson, R., Gerrard, M., Hann, I. M., Eden, O. B., Carter, R. L., & Langrish, V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1083 · Cited by 64
Self-citation
Cited by
Outcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
Dunleavy, K., Pittaluga, S., Shovlin, M., Steinberg, S. M., Cole, D., Grant, C., Widemann, B., Staudt, L. M., Jaffe, E. S., Little, R. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1308392 · Cited by 360
O'Leary, M., Krailo, M., Anderson, J. R., & Reaman, G. H. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.07.008 · Cited by 293
Minard-Colin, V., Brugières, L., Reiter, A., Cairo, M. S., Gross, T. G., Woessmann, W., Burkhardt, B., Sandlund, J. T., Williams, D., Pillon, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5827 · Cited by 290
Self-citationLeventaki, V., Rodic, V., Tripp, S. R., Bayerl, M. G., Perkins, S. L., Barnette, P., Schiffman, J. D., & Miles, R. R. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09243.x · Cited by 26
Self-citation
Metadata
- Authors
- Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S. L., McCarthy, K., Cairo, M. S., & for the FAB/LMB96 International Study Committee
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-11-28
- Volume
- 109
- Issue
- 7
- Pages
- 2773-2780
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2045940197
- Cited by
- 430
- References
- 11
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. https://app.cochat.ai/papers/10.1182/blood-2006-07-036673
- The paper
- Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S. L., McCarthy, K., Cairo, M. S., & for the FAB/LMB96 International Study Committee. (2007). Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. https://doi.org/10.1182/blood-2006-07-036673
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.